Bavarian Nordic Names Tarja Stenvall as New CEO
10 Articles
10 Articles
The Bavarian Nordic vaccine manufacturer named Sanofi Tarja Stenvall's ex-executive as its next director-president, replacing Paul Chaplin. Exclusive material for subscribers. To have full access, access the material link and register.
Bavarian Nordic Appoints Former Sanofi Executive as CEO
Bavarian Nordic A/S appointed former Sanofi executive Tarja Stenvall as its new chief executive officer, resetting leadership after a failed takeover bid led both the chairman and CEO to step down from the vaccine maker.
BT
Earlier this year, Bavarian Nordic announced that the company's CEO would step down. Now, a successor has been appointed.
Forbes España
diarioestrategia.clThe Danish laboratory Bavarian Nordic has announced the appointment of Tarja Stenvall as new deputy councillor and president of the company, with effect from 15 October, in place of Paul Chaplin, whose departure was announced at the beginning of the year. Stenvall has more than 20 years of experience in management positions of the sector [...] La entrada The laboratory Bavarian Nordic appoints deputy councillor and president to Tarja Stenvall, c…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
